Evidence map›Paper›PMID 33479646›Full record

ArticleRSC medicinal chemistry2020

Identification of

Hongtao Liu, Xinhai Jiang, Xinfeng Gao, Wenhua Tian, Chen Xu, Ruizhi Wang, Yanni Xu, Liping Wei, Feng Cao, Wenyan Li

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC medicinal chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 5 countries.

Hongtao LiuDepartment of Pharmacy , Hebei General Hospital , Shijiazhuang 05005 , China.
Xinhai JiangNHC Key Laboratory of Biotechnology of Antibiotics , Institute of Medicinal Biotechnology , Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS&PUMC) , Beijing 100050 , China . Email: xuyanniwendeng@hotmail.com.
Xinfeng GaoHebei Key Laboratory of Organic Functional Molecules , College of Chemistry and Materials Science , Hebei Normal University , Shijiazhuang , 050024 , China . Email: wyli8512@mail.hebtu.edu.cn.
Wenhua TianHebei Key Laboratory of Organic Functional Molecules , College of Chemistry and Materials Science , Hebei Normal University , Shijiazhuang , 050024 , China . Email: wyli8512@mail.hebtu.edu.cn.
Chen XuHebei Key Laboratory of Organic Functional Molecules , College of Chemistry and Materials Science , Hebei Normal University , Shijiazhuang , 050024 , China . Email: wyli8512@mail.hebtu.edu.cn.
Ruizhi WangHebei Key Laboratory of Organic Functional Molecules , College of Chemistry and Materials Science , Hebei Normal University , Shijiazhuang , 050024 , China . Email: wyli8512@mail.hebtu.edu.cn.
Yanni XuNHC Key Laboratory of Biotechnology of Antibiotics , Institute of Medicinal Biotechnology , Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS&PUMC) , Beijing 100050 , China . Email: xuyanniwendeng@hotmail.com.
Liping WeiDepartment of Cardiology , Tianjin Union Medical Center , Nankai University Affiliated Hospital , 190 Jieyuan Road, Hongqiao , Tianjin 300121 , P. R. China.
Feng CaoDepartment of Cardiology & National Clinical Research Center of Geriatrics Disease , Chinese PLA General Hospital , Beijing 100853 , China.
Wenyan LiHebei Key Laboratory of Organic Functional Molecules , College of Chemistry and Materials Science , Hebei Normal University , Shijiazhuang , 050024 , China . Email: wyli8512@mail.hebtu.edu.cn.ORCID 0000-0003-3769-9997
Shijiazhuang University · CNAcademy of Medical Sciences · GBChinese PLA General Hospital · CNNankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ATP binding cassette transporter A1 (ABCA1) is a critical transporter that mediates cellular cholesterol efflux from macrophages to apolipoprotein A-I (ApoA-I). Therefore, increasing the expression level of ABCA1 is anti-atherogenic and ABCA1 expression upregulators have become novel choices for atherosclerosis treatment. In this study, a series of

Identifiers

PMID33479646
PMCPMC7593777
OpenAlexW3011937367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.